We initially identified protein tyrosine kinase 6 (PTK6) as a critical mediator of anoikis resistance of breast cancer cells in a functional genomic screen designed to identify regulators of anchorage-independent survival [2]. The gene discussed is PTK6; the disease is breast carcinoma.